Expand Your Network
For more than 30 years, decision-makers have joined BioCentury events to network, partner, and debate critical issues facing the biopharma industry.
Join BioCentury On the Road
C-level networking, partnering and debate
BioCentury, MayTech Global Investments, and Panacea Venture Present the East-West Healthcare Reception. The perfect place for you to mix and mingle with leading executives and investors from across the biopharma ecosystem.
*This is an exclusive, invite-only event.
For three decades BioCentury has helped biotech executives and investors make business critical decisions and build larger networks with peers across the innovation ecosystem.
Celebrating its 25th year, Bio€quity Europe is where CEOs and investors gather to network, partner, and debate critical issues facing the biotech industry.
Put BioCentury to Work for You
Meet decision-makers in an intimate setting designed for networking and debate.
Hear from industry's most influential minds and leading experts
Gain powerful insight, tangible solutions, and practical advice
Meet emerging new companies selected to present by BioCentury
Access related content hand-picked by BioCentury industry experts
Research presenting companies through BioCentury's BCIQ database
Understand the landscape via exclusive reports and “Scene Setter” presentations
Meet potential partners and investors
Schedule 1x1 meetings with industry peers
Forge lasting relationships
Share your insights
Reach the right people at BioCentury’s C-level events.
Find the right investors and partners
Join the Presenting Company Class at a BioCentury event and pitch to VCs and biopharma BD&L leaders looking for deals.
BioCentury Sponsored Events
After the worst downturn in biotech history, are there finally signs of optimism heading into the second half?
Join BioCentury and Oppenheimer & Co. for an in-depth discussion with investors and pharma deal-makers about where the biotech market is headed.
Register (complimentary) to join live and ask questions, or watch the recorded version at your convenience.
Hosted by BioCentury & Oppenheimer
Marking the 31st edition of BioCentury’s “Back to School” report, BioCentury and Oppenheimer & Co. bring together a panel of experienced thought leaders to discuss the ingredients for creating and growing biotechs to the highest market cap tier, and how the fundamentals will play out in the industry following the market reset:
- How to pick your lead asset
- When is the right time to partner
- How to optimize around probability of success
- Where to fight for investor attention
- And much more.
Hosted by BioCentury & Oppenheimer
The drug price-setting provisions of the Inflation Reduction Act (IRA) will reconfigure the commercial landscape in the U.S., forcing biopharma companies and their investors to develop new strategies for R&D and business success.
Hosted by BioCentury & Putnam Associates
In this webinar, key opinion leaders from Owkin, Bristol-Myers Squibb and CancerLinQ gather to discuss how data-driven Covariate Adjustment improves clinical trials by increasing statistical power and widening eligibility criteria.
Hosted by BioCentury & Owkin
Industry KOL's discuss the current state of AI in oncology, and how building research networks in a privacy-preserving way is key for unlocking insights from the vast amount of patient data in hospitals and research centers to accelerate drug discovery.
Hosted by BioCentury & Owkin
Past Events
Join BioCentury, BIA, and special guests for our second annual CEO and investor dialogue on the sidelines of the Jefferies London Healthcare Conference. Register today. Space is limited.
For over a decade, BioCentury and BayHelix and our partners have brought together a global community of C-suite executives and investors focused on biopharma innovation and cross-border collaboration.
At BioCentury Grand Rounds, discover the next wave of biotech breakthroughs and the people driving them. Be part of the dialogue solving today’s problems in translation to enable tomorrow’s medicines.
For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner, and debate critical issues facing the biotech industry today.
In 2024, BioCentury and BayHelix bring the 3rd East-West Biopharma Summit to Singapore, where 20 years of government-led investment in science, talent and infrastructure has set the stage for the life sciences industry to carry the ball forward.
BioCentury and BIA present a special event, with special guests on the sidelines of the Jefferies London Healthcare Conference for a CEO and investor event you won't forget. Space is limited.
For a decade, BioCentury, BayHelix, and McKinsey & Company have brought together a C-level biopharma community to debate, network, and partner.
BioCentury and BayHelix present the East-West BioPharma Summit (Oct. 2-4, 2023, Boston/Cambridge). Along with two additional bonus days of virtual 1x1 meetings (Oct. 5-6, 2023).
In 2023, BioCentury hits the road to organize three educational and networking events in Amsterdam, London, and Boston. Launching this series is an in-depth interview with Europe’s top Regulator.
Bio€quity Europe is the industry’s premier CEO and investor conference. Join the discussion in Dublin or attend from home via a digital pass. Plus take advantage of two bonus days of digital one-to-one meetings.
The world has changed: Emerging biopharmas in the U.S., Europe and Asia now face the same dilemma: How do you globalize to deliver innovation to patients and achieve an ROI for investors?
Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Milan or attend the full event via our digital platform, May 16-18, 2022.
Chinese biotechs and medtechs race across the Bridge to Innovation. The 8th BioCentury-BayHelix China Healthcare Summit showcases the China story, promising to have a lasting impact on the global biopharma industry.
Europe's premier international showcase for financial dealmakers and biopharma C-suite executives to meet rising biotechs.
BioCentury and BayHelix Present: The 7th China Healthcare Summit - Doubling Down on Innovation.
BioCentury and BayHelix Present: The 6th China Healthcare Summit - China In The World.
Bio€quity Europe transformed conferences with its turf-neutral approach, inviting finance, business development, and licensing experts to connect with curated Presenting Companies.
Bio€quity Europe is the seminal industry event for financial dealmakers looking for life science companies positioning themselves to attract capital, and for pharmaceutical professionals to assess prospects.
China's Globally Facing Future: The China Summit is the event for biopharma and life sciences executives and investors to see the innovation, business and policy transformations taking place in China.
Supported Industry Events
The HealthTech Investor Summit on 9-11 December in Bruges, Belgium is the only event in Europe connecting healthtech entrepreneurs with the investors and mentors they need to succeed.
The future lies at the intersection of health and tech – but moonshots need rockets, and rockets need fuel. This Summit helps Europe’s brightest healthtech, medtech and digital health stars connect with investors aiming for real impact!
Join KoreaBIO, Sidley and BioCentury at the Nasdaq Entrepreneurial Center for an exciting in-person event where innovative companies will showcase their investment opportunities. Network with top industry professionals, investors, and entrepreneurs to discover the next big thing in the world of finance. Meet promising Korean and International Biotech Startups and investors, seize collaboration opportunities.
Don't miss out on this unique chance to take your business to the next level. See you there!
This conference is an exclusive global partnering and investor forum that brings together senior executives and CEOs, heads of research and development, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us in February, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers from around the globe.